Clarity Pharmaceuticals' Net Loss Widens to AU$42 Million in Fiscal Year 2024; Shares Rise 4%
Clarity Pharmaceuticals' Net Loss Widens to AU$42 Million in Fiscal Year 2024; Shares Rise 4%
Clarity Pharmaceuticals的净亏损在2024财年扩大至4200万澳元；股价上涨4%
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间